Medicover AB (publ) (MCOV_B) Q2 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Medicover Ab Class B.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.776 Welcome to the MediCover Q2 2025 report presentation. 00:00:04.776 -- 00:00:09.180 For the first part of the conference call, the participants will be in listen-only mode. 00:00:09.180 -- 00:00:14.246 During the questions and answers session, participants are able to ask questions by dialing 00:00:14.246 -- 00:00:19.872 pound key 5 on their telephone keypad. Now I will hand the conference over to the speakers, 00:00:19.872 -- 00:00:25.876 CEO John Stubbington and CFO Anand Patel. Please go ahead. 00:00:26.272 -- 00:00:32.019 Good morning, everybody. It's John here and welcome to our presentation for 00:00:32.019 -- 00:00:37.065 Q2. As you can see here on the headline, we've 00:00:37.065 -- 00:00:42.352 sort of positioned this as sustained high growth with strengthening profit margins, 00:00:42.352 -- 00:00:47.398 which I think is really, really good. When asked to frame the first quarter from 00:00:47.398 -- 00:00:50.562 many people, I think I positioned it as strong. 00:00:50.562 -- 00:00:54.166 I think to frame the second quarter, our positioning would be actually it's a little 00:00:54.166 -- 00:00:59.427 bit stronger. You can see strong growth coming through with good operational leverage. 00:00:59.427 -- 00:01:04.154 And this, of course, is improving our operating cash flow, which we're very, very pleased 00:01:04.154 -- 00:01:09.201 with. From a growth perspective, 17.1, you know, we're seeing 00:01:09.201 -- 00:01:15.130 growth in all markets, which is good. A little bit later on, we'll talk you through each 00:01:15.130 -- 00:01:20.958 of the markets and how it's progressing. But literally across the board, we're in a good 00:01:20.958 -- 00:01:25.730 position. Most of this growth is organic. As you can see, there's a relat...